Global Peptide Synthesis Market Size, Share and Trends Analysis Report, By Technology (Solid-Phase, Liquid-Phase, and Hybrid & Recombinant), By Product (Equipment and Reagents & Consumables), By End-User (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organization) Forecast Period (2022-2028)
The global peptide synthesis market is anticipated to grow at a CAGR of 5.4% during the forecast period (2022-2028). The usage of peptide in the pharmaceutical and consumer healthcare industries is driving the market’s expansion. The peptide have a wide range of uses in the treatment of malignancies, diabetes, and obesity, among other lifestyle problems. The rising prevalence of these metabolic and lifestyle diseases is opening the path for recombinant therapies to be used in oncology and metabolic illnesses.
Glucagon-like recombinant-1amide, for example, is a postprandially released recombinant that promotes insulin secretion and is widely used in pancreas therapy. As a result of the growing number of patients with Type 2 diabetes, demand for recombinant is predicted to rise, propelling the market forward throughout the forecast period. Increasing research activities and unique product approvals as a result of increased R&D investment, as well as the benefits of sophisticated recombinant synthesizers, have bolstered the peptide synthesis market’s growth over the period. For instance, in 2019, Rybelsus oral tablets were approved by the US Food and Drug Administration for regulating blood sugar in type 2 diabetes patients. Novo Nordisk has discovered therapy for the glucagon-like recombinant (GLP-1) receptor protein.
The benefits of recombinant, such as their relative ease of synthesis, easy availability, and low toxicity, have boosted their use in the pharmaceutical, nutritional, and cosmetic industries, resulting in a significant demand for quick advances in Peptide Synthesis technology. Throughout the projected period, North America is expected to dominate the entire Peptide Synthesis market. The growth in obesity, along with an increase in sedentary deskbound lifestyles and a lack of adequate food and physical activity, has resulted in a rise in chronic diseases such as diabetes in the United States, necessitating effective treatment.
Some major players in the market include AAPPTec., Bachem Holding AG, Biotage AB, CEM Corp., CSBio Company Inc, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in May 2019 Liberty PRO, the world’s first large-scale automated microwave Peptide Synthesis was introduced by CEM Corp. With unrivaled purity, speed, and waste reduction, the system can synthesize 1 kg of crude recombinant per batch in reaction vessels up to 15 liters, fueling market revenue share.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Technology
- By Product
- By End-User
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- AAPPTec., Bachem Holding AG, Biotage AB, CEM Corp., CSBio Company Inc., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Peptide Synthesis Market Report by Segment
By Technology
- Solid-Phase
- Liquid-Phase
- Hybrid & Recombinant
By Product
- Equipment
- Reagents & Consumables
By End-User
- Pharmaceutical & Biotechnology Companies
- Contract Development & Manufacturing Organization
Global Peptide Synthesis Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East & Africa
The report will be delivered within 48-72 hours after payment confirmation